(19)
(11) EP 4 437 093 A2

(12)

(88) Date of publication A3:
20.07.2023

(43) Date of publication:
02.10.2024 Bulletin 2024/40

(21) Application number: 22843953.5

(22) Date of filing: 22.11.2022
(51) International Patent Classification (IPC): 
C12N 9/22(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/22; C12Y 305/04005; C12N 9/78; C12Q 1/6806; C12Q 1/6869
 
C-Sets:
  1. C12Q 1/6806, C12Q 2521/501, C12Q 2521/539, C12Q 2525/117, C12Q 2525/191, C12Q 2525/301;
  2. C12Q 1/6869, C12Q 2521/501, C12Q 2521/539, C12Q 2525/117, C12Q 2525/191, C12Q 2525/301;

(86) International application number:
PCT/US2022/080345
(87) International publication number:
WO 2023/097226 (01.06.2023 Gazette 2023/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 24.11.2021 US 202163264513 P

(71) Applicant: New England Biolabs, Inc.
Ipswich, MA 01938-2723 (US)

(72) Inventors:
  • VAISVILA, Romualdas
    Ipswich, MA 01938 (US)
  • JOHNSON, Sean, R.
    Ipswich, MA 01938 (US)
  • SUN, Zhiyi
    Ipswich, MA 01938 (US)
  • EVANS, Thomas, C.
    Ipswich, MA 01938 (US)

(74) Representative: Griffin, Philippa Jane et al
Mathys & Squire The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) DOUBLE-STRANDED DNA DEAMINASES